Characterization of monoclonal antibodies directed against the rat neurotensin receptor NTS1

Journal of Receptors and Signal Transduction

Volumn 26, Issue 5-6, 2006, Pages 395-415

  Niebauer, Ronald T ^a   White, Jim F ^a   Fei, Zhizhong ^a   Grisshammer, Reinhard ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Antibody receptor complex; Cocrystallization; G protein coupled receptor; Monoclonal Antibody; Neurotensin receptor

Indexed keywords

G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; LIGAND; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; NEUROTENSIN RECEPTOR; RECEPTOR ANTIBODY; SODIUM CHLORIDE;

ANIMAL CELL; ANTIBODY AFFINITY; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; CONTROLLED STUDY; CRYSTAL; CRYSTALLIZATION; EPITOPE MAPPING; GEL PERMEATION CHROMATOGRAPHY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; RAT; RECEPTOR AFFINITY; STRUCTURE ANALYSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; BINDING SITES; CRYSTALLIZATION; EPITOPE MAPPING; IMMUNOGLOBULIN FAB FRAGMENTS; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROTENSIN; SODIUM CHLORIDE;

EID: 33845223751     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.1080/10799890600928228     Document Type: Conference Paper

References (49)

1. Vassilatis DK, Hohmann JG, Zeng H, Li F, Ranchalis JE, Mortrud MT, Brown A, Rodriguez SS, Weller JR, Wright AC, Bergmann JE, Gaitanaris GA. The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci USA 2003, 100, 4903-4908.
2. Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002, 3, 639-650.
3. Klabunde T, Hessler G. Drug design strategies for targeting G-protein-coupled receptors. Chem Biochem 2002, 3, 928-944.
4. Loll PJ. Membrane protein structural biology: The high throughput challenge. J Struct Biol 2003, 142, 144-153.
5. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289, 739-745.
6. Li J, Edwards PC, Burghammer M, Villa C, Schertler GFX. Structure of bovine rhodopsin in a trigonal crystal form. J Mol Biol 2004, 343, 1409-1438.
7. De Grip WJ. Thermal stability of rhodopsin and opsin in some novel detergents. Methods Enzymol 1982, 81, 256-265.
8. Sarramegna V, Talmont F, Demange P, Milon A. Heterologous expression of G-protein-coupled receptors: Comparison of expression systems from the stand-point of large-scale production and purification. Cell Mol Life Sci 2003, 60, 1529-1546.
9. Lundstrom K. Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins. Biochim Biophys Acta 2003, 1610, 90-96.
10. Niebauer RT, Robinson AS. Exceptional total and functional yields of the human adenosine (A2a) receptor expressed in the yeast Saccharomyces cerevisiae. Protein Expr Purif 2006, 46, 204-211.
11. Ohtaki T, Ogi K, Masuda Y, Mitsuoka K, Fujiyoshi Y, Kitada C, Sawada H, Onda H, Fujino M. Expression, purification, and reconstitution of receptor for pituitary adenylate cyclase-activating polypeptide: Large-scale purification of a functionally active G protein-coupled receptor produced in Sf9 insect cells. J Biol Chem 1998, 273, 15464-15473.
12. Reeves PJ, Kim J-M, Khorana HG. Structure and function in rhodopsin: A tetracycline-inducible system in stable mammalian cell lines for high-level expression of opsin mutants. Proc Natl Acad Sci USA 2002, 99, 13413-13418.
13. Warne T, Chirnside J, Schertler GFX. Expression and purification of truncated, nonglycosylated turkey β-adrenergic receptors for crystallization. Biochim Biophys Acta 2003, 1610, 133-140.
14. White JF, Trinh LB, Shiloach J, Grisshammer R. Automated large-scale purification of a G-protein-coupled receptor for neurotensin. FEBS Lett 2004, 564, 289-293.
15. Banères JL, Mesnier D, Martin A, Joubert L, Dumuis A, Bockaert J. Molecular characterization of a purified 5-HT4 receptor: A structural basis for drug efficacy. J Biol Chem 2005, 280, 20253-20260.
16. Banères J-L, Martin A, Hullot P, Girard J-P, Rossi J-C, Parello J. Structure-based analysis of GPCR function: Conformational adaptation of both agonist and receptor upon leukotriene B4 binding to recombinant BLT1. J Mol Biol 2003, 329, 801-814.
17. Banères J-L, Parello J. Structure-based analysis of GPCR function: Evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J Mol Biol 2003, 329, 815-829.
18. Kiefer H, Maier K, Vogel R. Refolding of G-protein-coupled receptors from inclusion bodies produced in Escherichia coli. Biochem Soc Trans 1999, 27, 908-912.
19. Kiefer H, Vogel R, Maier K. Bacterial expression of G-protein-coupled receptors: Prediction of expression levels from sequence. Receptors Channels 2000, 7, 109-119.
20. Hulme EC, Curtis CAM. Purification of recombinant M1 muscarinic acetylcholine receptor. Biochem Soc Trans 1998, 26, S361.
21. Klaassen CHW, Bovee-Geurts PHM, DeCaluwé GLJ, DeGrip WJ. Large-scale production and purification of functional recombinant bovine rhodopsin with the use of the baculovirus expression system. Biochem J 1999, 342, 293-300.
22. Kobilka BK. Amino and carboxyl terminal modifications to facilitate the production and purification of a G protein-coupled receptor. Anal Biochem 1995, 231, 269-271.
23. Weiß HM, Grisshammer R. Purification and characterization of the human adenosine A2a receptor functionally expressed in Escherichia coli. Eur J Biochem 2002, 269, 82-92.
24. Yeliseev AA, Wong KK, Soubias O, Gawrisch K. Expression of human peripheral cannabinoid receptor for structural studies. Protein Sci 2005, 14, 2638-2653.
25. Tanaka K, Masu M, Nakanishi S. Structure and functional expression of the cloned rat neurotensin receptor. Neuron 1990, 4, 847-854.
26. Ostermeier C, Iwata S, Ludwig B, Michel H. Fv fragment-mediated crystallization of the membrane protein bacterial cytochrome c oxidase. Nat Struct Biol 1995, 2, 842-846.
27. Hunte C, Koepke J, Lange C, Rossmanith T, Michel H. Structure at 2.3 Å resolution of the cytochrome bc1 complex from the yeast Saccharomyces cerevisiae co-crystallized with an antibody Fv fragment. Structure Fold Des 2000, 8, 669-684.
28. + channel-Fab complex at 2.0 Å resolution. Nature 2001, 414, 43-48.
29. + channel. Nature 2003, 423, 33-41.
30. Dutzler R, Campbell EB, MacKinnon R. Gating the selectivity filter in ClC chloride channels. Science 2003, 300, 108-112.
31. Hunte C, Michel H. Crystallisation of membrane proteins mediated by antibody fragments. Curr Opin Struct Biol 2002, 12, 503-508.
32. Tucker J, Grisshammer R. Purification of a rat neurotensin receptor expressed in Escherichia coli. Biochem J 1996, 317, 891-899.
33. Grisshammer R, Tucker J. Quantitative evaluation of neurotensin receptor purification by immobilized metal affinity chromatography. Protein Expr Purif 1997, 11, 53-60.
34. Dougherty WG, Cary SM, Parks TD. Molecular genetic analysis of a plant virus polyprotein cleavage site: A model. Virology 1989, 171, 356-364.
35. Kapust RB, Tözsér J, Copeland TD, Waugh DS. The P1′ specificity of tobacco etch virus protease. Biochem Biophys Res Comm 2002, 294, 949-955.
36. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272, 872-877.
37. Grisshammer R, Averbeck P, Sohal AK. Improved purification of a rat neurotensin receptor expressed in Escherichia coli. Biochem Soc Trans 1999, 27, 899-903.
38. Schaffner W, Weissmann C. A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal Biochem 1973, 56, 502-514.
39. Hodges RS, Heaton RJ, Parker JM, Molday L, Molday RS. Antigen-antibody interaction. Synthetic peptides define linear antigenic determinants recognized by monoclonal antibodies directed to the cytoplasmic carboxyl terminus of rhodopsin. J Biol Chem 1988, 263, 11768-11775.
40. + antiporter of Escherichia coli. FEBS Lett 1998, 441, 53-58.
41. MacKenzie D, Arendt A, Hargrave P, McDowell JH, Molday RS. Localization of binding sites for carboxyl terminal specific anti-rhodopsin monoclonal antibodies using synthetic peptides. Biochemistry 1984, 23, 6544-6549.
42. Adamus G, Zam ZS, Arendt A, Palczewski K, McDowell JH, Hargrave PA. Antirhodopsin monoclonal antibodies of defined specificity: Characterization and application. Vision Res 1991, 31, 17-31.
43. Molday RS, MacKenzie D. Monoclonal antibodies to rhodopsin: Characterization, cross-reactivity, and application as structural probes. Biochemistry 1983, 22, 653-660.
44. Oprian DD, Molday RS, Kaufman RJ, Khorana HG. Expression of a synthetic bovine rhodopsin gene in monkey kidney cells. Proc Natl Acad Sci USA 1987, 84, 8874-8878.
45. Lebesgue D, Wallukat G, Mijares A, Granier C, Argibay J, Hoebeke J. An agonist-like monoclonal antibody against the human beta2-adrenoceptor. Eur J Pharmacol 1998, 348, 123-133.
46. Elies R, Fu LX, Eftekhari P, Wallukat G, Schulze W, Granier C, Hjalmarson A, Hoebeke J. Immunochemical and functional characterization of an agonist-like monoclonal antibody against the M2 acetylcholine receptor. Eur J Biochem 1998, 251, 659-666.
47. Chabre M, le Maire M. Monomeric G-protein-coupled receptor as a functional unit. Biochemistry 2005, 44, 9395-9403.
48. Goldberg ME, Djavadi-Ohaniance L. Methods for measurement of antibody/antigen affinity based on ELISA and RIA. Curr Opin Immunol 1993, 5, 278-281.
49. Röthlisberger D, Pos KM, Plückthun A. An antibody library for stabilizing and crystallizing membrane proteins-Selecting binders to the citrate carrier CitS. FEBS Lett 2004, 564, 340-348.